Insurance Denial Puts Boynton Beach Patient at Risk After DVT

Insurance Denial Puts Boynton Beach Patient at Risk After DVT

Boca Raton, FL – In a concerning case highlighting systemic issues within healthcare, a Boynton Beach resident was unable to secure their full, prescribed dosage of life-saving medication due to an insurance denial, following their discharge from the hospital for deep vein thrombosis (DVT). The patient, who had been stabilized under Dr. Ben Soffer’s care, was prescribed Eliquis at an initial dose of 10 mg twice daily for one week, transitioning to 5 mg twice daily thereafter—a regimen critical for preventing potentially fatal blood clots.

Dr. Soffer, aware of the urgency of DVT treatment, tried to work with the pharmacy and secure prior authorization for the 10 mg dosage. However, the authorization system was unresponsive due to weekend closures, leaving the patient’s medication in limbo at a critical time. The insurance provider’s guidelines, rigidly covering only the 5 mg dosage without accommodating Dr. Soffer’s medical judgment, blocked immediate access to the full prescribed dose.

"This system is clearly broken if a patient, just discharged from the hospital with a life-threatening condition, can’t get their full, prescribed medication because insurance companies aren’t available to approve it on the weekend," Dr. Soffer said. "The insurance company’s policy denies the initial, medically necessary dose, yet a doctor’s prescription should be what guides treatment, not corporate guidelines set without regard to the patient’s immediate needs."

In an effort to work within the restrictive policy, Dr. Soffer adjusted the prescription to reflect the insurance-covered 5 mg twice-daily dosage so that the patient could at least have access to some medication without delay. This temporary workaround enables the patient to begin treatment immediately, but they will exhaust their supply before the end of the month, requiring an additional refill sooner than anticipated—a consequence of the insurer’s inflexible guidelines.

Dr. Soffer voiced his frustration with the insurance industry’s profit-driven policies, which he believes endanger patients by overriding physician expertise. “The priority should be patient safety, not corporate profit. By forcing doctors and patients to jump through these hoops, insurance companies are essentially practicing medicine without a license,” he said.

This incident brings to light the systemic risk posed by insurance policies that override urgent medical needs with restrictive and inflexible guidelines, especially during non-business hours. Dr. Soffer and other advocates are calling for reform, arguing that insurance companies should not interfere with time-sensitive medical decisions, particularly in life-threatening cases.

Until changes are made, similar cases will continue to put patients like this Boynton Beach resident in danger. For now, Dr. Soffer and his patient hope this workaround will be enough to stabilize the patient’s condition in the immediate term, even as long-term solutions remain limited by insurance constraints.